Holdings
Emerald Mutual Fund Advisers Trust
As of Sep 30, 2026, Emerald Mutual Fund Advisers Trust reported 182 positions worth US$2.45B. Largest: F/M Emerald Life Sciences Innovation ETF, Travere Therapeutics, Inc. and Corcept Therapeutics Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| F/M Emerald Life Sciences Innovation ETF | 2M | US$89M | new | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 985K | US$58M | −47,177 | Sep 30, 2026 |
| Corcept Therapeutics Incorporated | 474K | US$54.6M | +8,979 | Sep 30, 2026 |
| InterDigital, Inc. | 148K | US$48.1M | −602 | Sep 30, 2026 |
| Sensient Technologies Corporation | 307K | US$40.1M | +71,554 | Sep 30, 2026 |
| Cohu, Inc. | 544K | US$37.1M | +10,170 | Sep 30, 2026 |
| Plexus Corp. | 136K | US$35.5M | +1,120 | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 1.09M | US$34.8M | +56,347 | Sep 30, 2026 |
| Mercury Systems Inc | 414K | US$34.4M | +2,060 | Sep 30, 2026 |
| AAR Corp. | 337K | US$34.2M | +40 | Sep 30, 2026 |